Glycomet: Advanced Blood Glucose Management for Type 2 Diabetes
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.24 | $43.39 (0%) | 🛒 Add to cart |
| 270 | $0.21 | $65.08 $57.52 (12%) | 🛒 Add to cart |
| 360 | $0.20
Best per pill | $86.78 $71.64 (17%) | 🛒 Add to cart |
Similar products
Glycomet is a widely prescribed oral antidiabetic medication containing metformin hydrochloride, designed to help manage blood sugar levels in individuals with type 2 diabetes. As a first-line therapy, it works by reducing hepatic glucose production and improving insulin sensitivity in peripheral tissues. Its efficacy, safety profile, and long-standing use make it a cornerstone in diabetes treatment protocols worldwide. Proper usage under medical supervision can significantly aid in achieving glycemic targets and reducing the risk of diabetes-related complications.
Features
- Contains metformin hydrochloride as the active ingredient
- Available in various strengths: 500 mg, 850 mg, and 1000 mg tablets
- Immediate-release and extended-release formulations
- White, film-coated, oblong tablets with functional score lines
- Manufactured under strict pharmaceutical quality standards
Benefits
- Effectively lowers and stabilizes blood glucose levels
- Reduces the risk of diabetes-related macrovascular and microvascular complications
- May support modest weight loss or weight neutrality, unlike some other antidiabetics
- Does not typically cause hypoglycemia when used as monotherapy
- May improve lipid profiles and offer cardiovascular benefits
- Cost-effective with widespread insurance coverage
Common use
Glycomet is primarily indicated for the management of type 2 diabetes mellitus in adults and children over 10 years of age. It is used as monotherapy or in combination with other oral antidiabetic agents or insulin when glycemic targets are not achieved with lifestyle modifications alone. It may also be used off-label for conditions such as polycystic ovary syndrome (PCOS) and prediabetes, under physician guidance.
Dosage and direction
The initial recommended dose is typically 500 mg twice daily or 850 mg once daily, taken with meals to minimize gastrointestinal side effects. Dosage may be gradually increased at weekly intervals based on glycemic response and tolerance, up to a maximum of 2550 mg per day in divided doses. For extended-release formulations, the usual starting dose is 500 mg once daily with the evening meal, which may be increased to a maximum of 2000 mg daily. Always follow the specific dosing instructions provided by the prescribing healthcare professional.
Precautions
- Renal function should be assessed before initiation and regularly during treatment
- Avoid use in patients with conditions that may predispose to renal impairment
- Temporarily discontinue prior to iodinated contrast imaging procedures
- Use with caution in elderly patients and those with hepatic impairment
- Monitor vitamin B12 levels periodically during long-term therapy
- Inform healthcare providers of Glycomet use before surgical procedures
Contraindications
- Hypersensitivity to metformin or any component of the formulation
- Severe renal impairment (eGFR below 30 mL/min/1.73m²)
- Acute or chronic metabolic acidosis, including diabetic ketoacidosis
- History of lactic acidosis
- Acute conditions that may affect renal function (dehydration, severe infection, shock)
Possible side effects
- Gastrointestinal disturbances: nausea, vomiting, diarrhea, abdominal discomfort (usually transient)
- Metallic taste
- Lactic acidosis (rare but serious; symptoms include malaise, myalgia, respiratory distress)
- Vitamin B12 deficiency with long-term use
- Skin reactions such as erythema or urticaria (rare)
Drug interaction
- Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, vancomycin) may compete for renal tubular secretion
- Alcohol increases the risk of lactic acidosis
- Glucocorticoids, diuretics, and sympathomimetics may reduce hypoglycemic effect
- Iodinated contrast media may increase risk of lactic acidosis
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure consistent glycemic control.
Overdose
Metformin overdose may lead to lactic acidosis, a medical emergency characterized by acid-base imbalance. Symptoms include vomiting, diarrhea, abdominal pain, tachycardia, hypothermia, and altered mental status. Hospitalization is required, with treatment focusing on supportive care and hemodialysis to remove metformin and correct acidosis.
Storage
Store at room temperature (15-30°C or 59-86°F) in a dry place, protected from light and moisture. Keep in the original container with the lid tightly closed. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Glycomet is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual response to therapy may vary. Always consult with your physician for personalized medical advice and before making any changes to your treatment regimen.
Reviews
Clinical studies and patient reports consistently demonstrate Glycomet’s effectiveness in managing type 2 diabetes. Many users report improved glycemic control within weeks of initiation, though some experience transient gastrointestinal side effects. Healthcare professionals appreciate its established safety profile and versatility in combination therapy. Long-term users often note stable glycemic management with proper dosage titration and adherence to dietary recommendations.